Endocytic Profiles of λ-Opioid receptor ligands determine the duration of rapid but not sustained camp responses

Molecular Pharmacology

Volumn 85, Issue 1, 2014, Pages 148-161

  Tudashki, Hanieh Bagheri ^a,b   Robertson, Derek N ^a   Schiller, Peter W ^b,c   Pineyro, Graciela ^a,b  

^a UNIVERSITY OF MONTREAL   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP; DELTA OPIATE RECEPTOR; DELTA OPIATE RECEPTOR AGONIST; DELTORPHIN; GUANINE NUCLEOTIDE BINDING PROTEIN; LIGAND;

ARTICLE; BIOLUMINESCENCE RESONANCE ENERGY TRANSFER; CELL ACTIVATION; CONTROLLED STUDY; DRUG INHIBITION; EMBRYO; ENDOSOME; HUMAN; HUMAN CELL; INTERNALIZATION; PRIORITY JOURNAL; REACTION TIME; REAL TIME POLYMERASE CHAIN REACTION; SECOND MESSENGER; BIOSYNTHESIS; CELL STRAIN HEK293; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; ENDOCYTOSIS; METABOLISM; TIME; AGONISTS; ANTAGONISTS AND INHIBITORS; DRUG EFFECTS; HEK293 CELL LINE;

BIOLUMINESCENCE RESONANCE ENERGY TRANSFER TECHNIQUES; CYCLIC AMP; ENDOCYTOSIS; GTP-BINDING PROTEINS; HEK293 CELLS; HUMANS; LIGANDS; RECEPTORS, OPIOID, DELTA; TIME FACTORS;

EID: 84890783779     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.113.089003     Document Type: Article

References (50)

1. Archer-Lahlou E, Audet N, Amraei MG, Huard K, Paquin-Gobeil M, and Pineyro G (2009) Src promotes delta opioid receptor (DOR) desensitization by interfering with receptor recycling. J Cell Mol Med 13:147-163.
2. Arttamangkul S, Quillinan N, Low MJ, von Zastrow M, Pintar J, and Williams JT (2008) Differential activation and trafficking of micro-opioid receptors in brain slices. Mol Pharmacol 74:972-979.
3. Arttamangkul S, Torrecilla M, Kobayashi K, Okano H, and Williams JT (2006) Separation of mu-opioid receptor desensitization and internalization: Endogenous receptors in primary neuronal cultures. J Neurosci 26:4118-4125.
4. Audet N, Archer-Lahlou E, Richard-Lalonde M, and Piñeyro-Filpo G (2010) [Functional selectivity of opioid receptors ligands]. Med Sci (Paris) 26:734-739.
5. Audet N, Charfi I, Mnie-Filali O, Amraei M, Chabot-Doré AJ, Millecamps M, Stone LS, and Pineyro G (2012) Differential association of receptor-Gbg complexes with b-arrestin2 determines recycling bias and potential for tolerance of d opioid receptor agonists. J Neurosci 32:4827-4840.
6. Audet N, Galés C, Archer-Lahlou E, Vallières M, Schiller PW, Bouvier M, and Pineyro G (2008) Bioluminescence resonance energy transfer assays reveal ligand-specific conformational changes within preformed signaling complexes containing delta-opioid receptors and heterotrimeric G proteins. J Biol Chem 283: 15078-15088.
7. Beaudry H, Proteau-Gagné A, Li S, Dory Y, Chavkin C, and Gendron L (2009) Differential noxious and motor tolerance of chronic delta opioid receptor agonists in rodents. Neuroscience 161:381-391.
8. Black JW and Leff P (1983) Operational models of pharmacological agonism. Proc R Soc Lond B Biol Sci 220:141-162.
9. Breton B, Lagacé M, and Bouvier M (2010) Combining resonance energy transfer methods reveals a complex between the alpha2A-adrenergic receptor, Galphai1-beta1gamma2, and GRK2. FASEB J 24:4733-4743.
10. Calebiro D, Nikolaev VO, Gagliani MC, de Filippis T, Dees C, Tacchetti C, Persani L, and Lohse MJ (2009) Persistent cAMP-signals triggered by internalized G-proteincoupled receptors. PLoS Biol 7:e1000172.
11. Charfi I, Nagi K, Mnie-Filali O, Thibault D, Balboni G, Schiller PW, Trudeau LE, and Pineyro G (2013) Ligand-and cell-dependent determinants of internalization and cAMP modulation by delta opioid receptor (DOR) agonists. Cell Mol Life Sci, in press.
12. Dang VC and Christie MJ (2012) Mechanisms of rapid opioid receptor desensitization, resensitization and tolerance in brain neurons. Br J Pharmacol 165: 1704-1716.
13. Doll C, Konietzko J, Pöll F, Koch T, Höllt V, and Schulz S (2011) Agonist-selective patterns of m-opioid receptor phosphorylation revealed by phosphosite-specific antibodies. Br J Pharmacol 164:298-307.
14. Edwards HV, Christian F, and Baillie GS (2012) cAMP: Novel concepts in compartmentalised signalling. Semin Cell Dev Biol 23:181-190.
15. Ferguson SS (2001) Evolving concepts in G protein-coupled receptor endocytosis: The role in receptor desensitization and signaling. Pharmacol Rev 53:1-24.
16. Ferrandon S, Feinstein TN, Castro M, Wang B, Bouley R, Potts JT, Gardella TJ, and Vilardaga JP (2009) Sustained cyclic AMP production by parathyroid hormone receptor endocytosis. Nat Chem Biol 5:734-742.
17. Finn AK and Whistler JL (2001) Endocytosis of the mu opioid receptor reduces tolerance and a cellular hallmark of opiate withdrawal. Neuron 32:829-839.
18. Galés C, Rebois RV, Hogue M, Trieu P, Breit A, Hébert TE, and Bouvier M (2005) Real-time monitoring of receptor and G-protein interactions in living cells. Nat Methods 2:177-184.
19. Galés C, Van Durm JJ, Schaak S, Pontier S, Percherancier Y, Audet M, Paris H, and Bouvier M (2006) Probing the activation-promoted structural rearrangements in preassembled receptor-G protein complexes. Nat Struct Mol Biol 13:778-786.
20. Gregory KJ, Sexton PM, Tobin AB, and Christopoulos A (2012) Stimulus bias provides evidence for conformational constraints in the structure of a G proteincoupled receptor. J Biol Chem 287:37066-37077.
21. Hamdan FF, Rochdi MD, Breton B, Fessart D, Michaud DE, Charest PG, Laporte SA, and BouvierM (2007) Unraveling G protein-coupled receptor endocytosis pathways using real-time monitoring of agonist-promoted interaction between beta-arrestins and AP-2. J Biol Chem 282:29089-29100.
22. He L, Kim JA, and Whistler JL (2009) Biomarkers of morphine tolerance and dependence are prevented by morphine-induced endocytosis of a mutant mu-opioid receptor. FASEB J 23:4327-4334.
23. Irannejad R, Tomshine JC, Tomshine JR, Chevalier M, Mahoney JP, Steyaert J, Rasmussen SG, Sunahara RK, El-Samad H, and Huang B et al. (2013) Conformational biosensors reveal GPCR signalling from endosomes. Nature 495:534-538.
24. Keith DE, Anton B, Murray SR, Zaki PA, Chu PC, Lissin DV, Monteillet-Agius G, Stewart PL, Evans CJ, and von Zastrow M (1998) mu-Opioid receptor internalization: Opiate drugs have differential effects on a conserved endocytic mechanism in vitro and in the mammalian brain. Mol Pharmacol 53:377-384.
25. Kenakin T and Christopoulos A (2013) Signalling bias in new drug discovery: Detection, quantification and therapeutic impact. Nat Rev Drug Discov 12:205-216.
26. Kenakin T, Watson C, Muniz-Medina V, Christopoulos A, and Novick S (2012) A simple method for quantifying functional selectivity and agonist bias. ACS Chem Neurosci 3:193-203.
27. Krupnick JG, Santini F, Gagnon AW, Keen JH, and Benovic JL (1997) Modulation of the arrestin-clathrin interaction in cells: Characterization of beta-arrestin dominant-negative mutants. J Biol Chem 272:32507-32512.
28. Leduc M, Breton B, Galés C, Le Gouill C, Bouvier M, Chemtob S, and Heveker N (2009) Functional selectivity of natural and synthetic prostaglandin EP4 receptor ligands. J Pharmacol Exp Ther 331:297-307.
29. Lefkowitz RJ (1998) G protein-coupled receptors. III. New roles for receptor kinases and beta-arrestins in receptor signaling and desensitization. J Biol Chem 273: 18677-18680.
30. Macia E, Ehrlich M, Massol R, Boucrot E, Brunner C, and Kirchhausen T (2006) Dynasore, a cell-permeable inhibitor of dynamin. Dev Cell 10:839-850.
31. Martini L and Whistler JL (2007) The role of mu opioid receptor desensitization and endocytosis in morphine tolerance and dependence. Curr Opin Neurobiol 17: 556-564.
32. Masri B, Salahpour A, Didriksen M, Ghisi V, Beaulieu JM, Gainetdinov RR, and Caron MG (2008) Antagonism of dopamine D2 receptor/beta-arrestin 2 interaction is a common property of clinically effective antipsychotics. Proc Natl Acad Sci USA 105:13656-13661.
33. McDowell TS (2003) Fentanyl decreases Ca21 currents in a population of capsaicinresponsive sensory neurons. Anesthesiology 98:223-231.
34. McPherson J, Rivero G, Baptist M, Llorente J, Al-Sabah S, Krasel C, Dewey WL, Bailey CP, Rosethorne EM, and Charlton SJ et al. (2010) m-opioid receptors: Correlation of agonist efficacy for signalling with ability to activate internalization. Mol Pharmacol 78:756-766.
35. Molinari P, Vezzi V, Sbraccia M, Grò C, Riitano D, Ambrosio C, Casella I, and Costa T (2010) Morphine-like opiates selectively antagonize receptor-arrestin interactions. J Biol Chem 285:12522-12535.
36. Mullershausen F, Zecri F, Cetin C, Billich A, Guerini D, and Seuwen K (2009) Persistent signaling induced by FTY720-phosphate is mediated by internalized S1P1 receptors. Nat Chem Biol 5:428-434.
37. Nagi K and Piñeyro G (2011) Regulation of opioid receptor signalling: Implications for the development of analgesic tolerance. Mol Brain 4:25.
38. Navratilova E, Eaton MC, Stropova D, Varga EV, Vanderah TW, Roeske WR, and Yamamura HI (2005) Morphine promotes phosphorylation of the human deltaopioid receptor at serine 363. Eur J Pharmacol 519:212-214.
39. Patierno S, Anselmi L, Jaramillo I, Scott D, Garcia R, and Sternini C (2011) Morphine induces m opioid receptor endocytosis in guinea pig enteric neurons following prolonged receptor activation. Gastroenterology 140:618-626.
40. Pradhan AA, Becker JA, Scherrer G, Tryoen-Toth P, Filliol D, Matifas A, Massotte D, Gavériaux-Ruff C, and Kieffer BL (2009) In vivo delta opioid receptor internalization controls behavioral effects of agonists. PLoS ONE 4:e5425.
41. Pradhan AA, Walwyn W, Nozaki C, Filliol D, Erbs E, Matifas A, Evans C, and Kieffer BL (2010) Ligand-directed trafficking of the d-opioid receptor in vivo: Two paths toward analgesic tolerance. J Neurosci 30:16459-16468.
42. Raehal KM, Schmid CL, Groer CE, and Bohn LM (2011) Functional selectivity at the m-opioid receptor: Implications for understanding opioid analgesia and tolerance. Pharmacol Rev 63:1001-1019.
43. Richard-Lalonde M, Nagi K, Audet N, Sleno R, Amraei M, Hogue M, Balboni G, Schiller PW, Bouvier M, and Hébert TE et al. (2013) Conformational dynamics of Kir3.1/Kir3.2 channel activation via d-opioid receptors. Mol Pharmacol 83: 416-428.
44. Salahpour A, Espinoza S, Masri B, Lam V, Barak LS, and Gainetdinov RR (2012) BRET biosensors to study GPCR biology, pharmacology, and signal transduction. Front Endocrinol (Lausanne) 3:105.
45. Thompson HM and McNiven MA (2006) Discovery of a new 'dynasore'. Nat Chem Biol 2:355-356.
46. Violin JD, DiPilato LM, Yildirim N, Elston TC, Zhang J, and Lefkowitz RJ (2008) beta2-adrenergic receptor signaling and desensitization elucidated by quantitative modeling of real time cAMP dynamics. J Biol Chem 283:2949-2961.
47. Violin JD and Lefkowitz RJ (2007) Beta-arrestin-biased ligands at seventransmembrane receptors. Trends Pharmacol Sci 28:416-422.
48. Williams JT, Ingram SL, Henderson G, Chavkin C, von Zastrow M, Schulz S, Koch T, Evans CJ, and Christie MJ (2013) Regulation of m-opioid receptors: Desensitization, phosphorylation, internalization, and tolerance. Pharmacol Rev 65: 223-254.
49. Zhang J, Ferguson SS, Law PY, Barak LS, and Caron MG (1999) Agonist-specific regulation of delta-opioid receptor trafficking by G protein-coupled receptor kinase and beta-arrestin. J Recept Signal Transduct Res 19:301-313.
50. Zheng H, Loh HH, and Law PY (2010) Agonist-selective signaling of G proteincoupled receptor: Mechanisms and implications. IUBMB Life 62:112-119.